VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $208,000 | -63.9% | 10,000 | +209.7% | 0.00% | -75.0% |
| Q3 2015 | $576,000 | -52.6% | 3,229 | -41.0% | 0.00% | -50.0% |
| Q2 2015 | $1,215,000 | -5.7% | 5,471 | -15.7% | 0.01% | 0.0% |
| Q1 2015 | $1,289,000 | +15.4% | 6,491 | -16.8% | 0.01% | +14.3% |
| Q4 2014 | $1,117,000 | -12.1% | 7,802 | -19.5% | 0.01% | -22.2% |
| Q3 2014 | $1,271,000 | +15.0% | 9,688 | +10.6% | 0.01% | +28.6% |
| Q2 2014 | $1,105,000 | +18.4% | 8,760 | +23.8% | 0.01% | 0.0% |
| Q1 2014 | $933,000 | +17.7% | 7,078 | +4.7% | 0.01% | +40.0% |
| Q4 2013 | $793,000 | +0.5% | 6,758 | -10.7% | 0.01% | 0.0% |
| Q3 2013 | $789,000 | +8.1% | 7,566 | -10.8% | 0.01% | +66.7% |
| Q2 2013 | $730,000 | – | 8,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |